Huawei plans for more AI pharma tie-ups, says healthcare president

Chinese technology conglomerate Huawei plans to expand ​its AI cooperation with ​local pharmaceutical firms into drug development and clinical ​practice, a senior executive said.

The move highlights Huawei’s ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical ‌companies are ⁠investing in ⁠modelling tools and automated laboratories to shorten development timelines and improve ​efficiency.